0 companies available
↑ ↓ to navigate Enter to select Esc to close
Merck & Co., Inc.
MRK
Pharmaceutical Preparations Last filing · Quarter 2 · Jun 30, 2026Export XLSX
| Ratios | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Margin | 72.97% | 74.80% | 76.32% | 73.17% | ||||||||||||||
Operating Margin | 9.58% | 32.64% | 31.03% | 3.92% | ||||||||||||||
Pretax Margin | 8.94% | 32.41% | 31.07% | 3.14% | ||||||||||||||
Effective Tax Rate | 46.72% | 13.31% | 14.06% | 80.04% | ||||||||||||||
Net Margin | 4.77% | 28.08% | 26.68% | 0.61% | ||||||||||||||
Current Ratio | - | 1.54x | 1.36x | 1.25x | ||||||||||||||
Debt to Equity | - | 1.60x | 1.53x | 1.83x | ||||||||||||||
Net Debt to Equity | - | 1.32x | 1.24x | 1.65x | ||||||||||||||
Asset Turnover | - | 47.50% | 54.79% | 56.35% | ||||||||||||||
Return on Equity | - | 34.66% | 36.91% | 0.97% | ||||||||||||||
Return on Assets | - | 13.34% | 14.62% | 0.34% |